NAPLEX (North American Pharmacist Licensure Examination) Practice Exam 2025 - Free NAPLEX Practice Questions and Study Guide

Question: 1 / 1820

For what condition are Glycoprotein IIb/IIIa Receptor Antagonists primarily used?

STEMI

HF

ACS or PCI +/- stent patients

Glycoprotein IIb/IIIa receptor antagonists are primarily used for patients with acute coronary syndrome (ACS) or those undergoing percutaneous coronary intervention (PCI) with or without stent placement. They are not typically used for patients with ST-elevation myocardial infarction (STEMI), heart failure (HF), or hypertension. In STEMI, other medications such as thrombolytics or angioplasty are typically used. For HF, medications to manage symptoms and improve heart function are used. Hypertension is typically managed with blood pressure lowering medications. Thus, the correct answer is option C as it specifies the appropriate indication for the use of glycoprotein IIb/IIIa receptor antagonists.

Get further explanation with Examzify DeepDiveBeta

Hypertension

Next Question

Report this question

Download NAPLEX (North American Pharmacist Licensure Examination) Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy